How to Stop Your Period Forever: Medical Options

Stopping your period permanently is possible through surgery, and stopping it indefinitely is achievable with several hormonal methods that can be maintained for years or even decades. The options range from a daily pill you could quit tomorrow to removing the uterus entirely. Which path makes sense depends on whether you want reversibility, how quickly you need bleeding to stop, your tolerance for side effects, and whether you have an underlying condition driving the decision. No single method is best for everyone, and “forever” means different things depending on which route you take.

Hormonal IUDs

A levonorgestrel-releasing intrauterine device (commonly known by brand names like Mirena or Liletta) is one of the most popular set-and-forget options for reducing or eliminating periods. The device sits in the uterus and releases a small, steady dose of progestin that thins the uterine lining over time. It does not, however, flip a switch on day one. A systematic review and meta-analysis found that almost no users experienced full amenorrhea in the first 90 days, while about 18% achieved at least one 90-day stretch without bleeding during the first year.1PubMed Central. Levonorgestrel intrauterine system associated amenorrhea: a systematic review and metaanalysis That percentage climbs with continued use. In a five-year study, menstrual bleeding was greatly reduced in most users, with a high rate of very light or absent periods, though some women discontinued specifically because of the amenorrhea itself.2Contraception. Five years’ experience with levonorgestrel-releasing IUDs

The trade-off with an IUD is patience. Irregular spotting in the early months is common, and complete period cessation is not guaranteed. If your primary goal is zero bleeding, an IUD is a strong long-term bet but a slow starter. On the other hand, once it settles in, it requires no daily effort and lasts five to eight years depending on the device.

The Depot Shot

Depot medroxyprogesterone acetate, usually called the Depo shot or DMPA, is an injection given every three months. It suppresses ovulation and thins the lining of the uterus, and it tends to eliminate periods more reliably and more quickly than an IUD. After a year of use, roughly half of users report amenorrhea, and the rate continues to rise the longer you stay on it. In studies of adolescents and young adults with disabilities seeking menstrual suppression, the depot shot was the most successful single method for achieving it.3PubMed. Menstrual Suppression in Pediatric and Adolescent Patients with Disabilities Ranging from Developmental to Acquired Conditions

The main concern with DMPA is bone density. Over four years of use, hip and spine bone mineral density declined by roughly 6 to 8% compared with less than 2% in non-users.4PubMed. Bone mineral density loss and recovery during 48 months in first-time users of depot medroxyprogesterone acetate The reassuring part is that bone density recovers after stopping the injections, with gains appearing as early as six months after the last shot and continuing over time.5PubMed. Bone density recovery after depot medroxyprogesterone acetate injectable contraception use Still, for someone planning truly indefinite use, the bone density question is worth discussing with a clinician, especially for younger users who are still building peak bone mass or older users approaching menopause.

Continuous Oral Contraceptives

Standard birth-control pills come in packs with a week of placebo pills that trigger a withdrawal bleed. If you skip the placebos and start a new pack immediately, you skip the bleed. This is continuous or extended-cycle use, and it has been studied for decades. A Cochrane systematic review of randomized trials found that bleeding patterns were either equivalent or improved with continuous dosing compared to the traditional cyclic approach.6Human Reproduction. Continuous versus cyclic use of combined oral contraceptives for contraception: systematic Cochrane review of randomized controlled trials A separate randomized trial found that moderate-to-heavy bleeding days were significantly fewer in continuous users compared to cyclic users.7The Journal of Clinical Endocrinology & Metabolism. Effects of Continuous Versus Cyclical Oral Contraception: A Randomized Controlled Trial

Continuous pills are the most accessible option because any standard combined pill can be used this way. The catch is breakthrough bleeding, especially in the first few months. When breakthrough spotting or bleeding lasts five or more days, one strategy is a short hormone-free break. A trial of continuous vaginal ring use found that removing the ring for four days when breakthrough bleeding appeared was more effective at resolving the bleeding than simply pushing through it.8PubMed. Frequency and management of breakthrough bleeding with continuous use of the transvaginal contraceptive ring: a randomized controlled trial This planned-break approach can be applied to pills, too, and most clinicians consider it a reasonable management tool during the adjustment phase. Users also reported fewer days of bloating and menstrual pain when taking pills continuously.9PubMed Central. Safety, efficacy and patient satisfaction with continuous daily administration of levonorgestrel/ethinylestradiol oral contraceptives

Subdermal Implants and Oral Progestins

The etonogestrel implant (sold as Nexplanon) is a small rod placed under the skin of the upper arm that releases progestin for up to three years. It commonly causes lighter or less frequent periods, and amenorrhea is one of the most common bleeding patterns at six months of use.10Contraception. The management of unacceptable bleeding patterns in etonogestrel-releasing contraceptive implant users However, the implant is also notorious for unpredictable spotting. Some users get no bleeding at all; others get irregular, annoying spotting that never fully settles. Of all hormonal methods, the implant is probably the hardest to predict in terms of bleeding outcome for any individual person.

Oral progestins taken continuously at higher doses represent another pharmacological route. Norethindrone at doses of 20 to 40 mg daily was shown as early as the 1950s to delay menstrual bleeding for up to seven months.11JAMA. DELAY OF MENSTRUATION WITH NORETHINDRONE, AN ORALLY GIVEN PROGESTATIONAL COMPOUND Long-term continuous progestin use at higher doses can cause thinning of the uterine lining (endometrial atrophy), which is why it works so well at suppressing periods but also why it requires medical oversight.12PubMed Central. Effect of norethisterone dose and duration in the management of abnormal uterine bleeding: a narrative review and case report Lower-dose norethindrone (around 5 mg) is commonly prescribed for menstrual suppression today, though the amenorrhea rate is lower than with the higher doses studied decades ago.

GnRH Agonists and Antagonists

Gonadotropin-releasing hormone (GnRH) agonists and the newer oral antagonists work by shutting down the hormonal signals from the brain that drive the menstrual cycle. They are among the most effective ways to achieve complete amenorrhea, and they do it quickly. GnRH agonists like leuprolide (Lupron) have been used for decades to manage endometriosis and fibroids, and they reliably stop periods within a month or two of starting treatment.

The problem is what happens to the rest of your body when estrogen plummets. Without “add-back” therapy (small replacement doses of estrogen and sometimes progestin), GnRH agonists cause menopausal symptoms like hot flashes, vaginal dryness, and bone loss. A study of adolescents treated with a GnRH agonist plus add-back therapy for endometriosis found that while bone density was generally maintained, a subset of patients still showed meaningfully low bone density scores, and this effect was not clearly related to how long they had been on treatment.13PubMed Central. Bone Density in Adolescents Treated with a GnRH Agonist and Add-Back Therapy for Endometriosis Because of these risks, GnRH agonists are typically used for limited periods rather than as a permanent solution.

A newer concept combines an oral GnRH antagonist (relugolix) with a form of estrogen to suppress ovulation and menstruation while preserving bone and cardiovascular health. Researchers have proposed this as a “life-cycle” approach that could provide continuous amenorrhea from adolescence through the menopausal transition.14PubMed Central. A concept for a new approach to combined oral contraception from adolescence to perimenopause This is still a conceptual framework rather than established practice, but it signals where the field is heading.

Endometrial Ablation

Endometrial ablation destroys the lining of the uterus using heat, cold, or energy. It is a minimally invasive outpatient procedure designed to dramatically reduce or stop menstrual bleeding. Unlike hormonal methods, ablation physically removes the tissue that bleeds each month. Many women do achieve amenorrhea afterward, and the procedure takes only minutes.

Ablation has important limitations. It is not recommended for anyone who might want to become pregnant in the future, because the damaged lining usually cannot support a pregnancy safely. It also does not always work permanently. A meta-analysis of prognostic factors for ablation failure found that younger age, prior tubal ligation, and pre-existing painful periods were all associated with a higher likelihood of needing a second procedure.15Obstetrics & Gynecology. Prognostic Factors for the Failure of Endometrial Ablation: A Systematic Review and Meta-analysis For women 40 or older who are finished with childbearing and whose primary complaint is heavy bleeding, ablation can be a good middle ground between hormones and hysterectomy. For younger women, the failure rate is high enough that many gynecologists steer them toward other options.

Hysterectomy

Removing the uterus is the only truly permanent way to stop periods. There is no lining left to shed. Hysterectomy is definitive, and for people with severe conditions like adenomyosis, large fibroids, or chronic heavy bleeding that has not responded to other treatments, it can be life-changing. The surgery can be done abdominally, vaginally, or laparoscopically, and recovery ranges from a few weeks to several months depending on the approach.

One underappreciated nuance involves the cervix. In a subtotal (also called supracervical) hysterectomy, the cervix is left in place. A randomized trial found that about 7% of women who had this type of surgery continued to experience cyclical bleeding afterward, because the remaining cervical tissue and any residual endometrium can still respond to hormonal signals.16New England Journal of Medicine. Outcomes after total versus subtotal abdominal hysterectomy A total hysterectomy, which removes the cervix as well, eliminates this possibility.

A separate question is what to do with the ovaries. Removing them (bilateral oophorectomy) triggers immediate surgical menopause, with all its consequences. Keeping them preserves ongoing hormone production, which matters for bone, heart, and brain health. A meta-analysis found that even keeping the ovaries during hysterectomy may somewhat reduce ovarian function compared to having an intact uterus.17PubMed Central. Effect of hysterectomy on ovarian function: a systematic review and meta-analysis And studies of postmenopausal women show that retained ovaries continue to produce meaningful levels of hormones, including estrogen and DHEA, well after menopause.18PubMed. Steroid hormone levels in postmenopausal hysterectomised women with and without ovarian conservation For most people, the current consensus favors keeping the ovaries unless there is a compelling medical reason to remove them, such as a strong family history of ovarian cancer.

Testosterone for Transmasculine Individuals

For transgender men and other transmasculine people, testosterone therapy typically stops menstruation as a welcome side effect of masculinizing hormone treatment. In a study of 74 patients started on low-dose intramuscular testosterone, 55% had cessation of menses within six months, about a third took six to twelve months, and roughly 7% had not achieved cessation by one year and were prescribed supplemental progestin.19PubMed Central. The Response of the Menstrual Cycle to Initiation of Hormonal Therapy in Transgender Men

Persistent menstruation on testosterone is more common than many people expect. A larger survey found that about 23% of participants reported ongoing menstruation more than six months after starting testosterone, and the delivery method mattered: people using testosterone gels or creams had substantially higher odds of persistent bleeding compared to those using injections.20PubMed Central. Persistent menstruation in transgender people using testosterone gender-affirming hormone therapy For transmasculine individuals for whom menstruation is a source of significant distress, adding a progestin-based method (like an IUD or the depot shot) on top of testosterone, or switching to injectable testosterone, are strategies clinicians commonly use.

When Menstrual Suppression Is a Medical Priority

Stopping periods is not purely an elective preference. For people managing endometriosis, continuous hormone use after surgery significantly reduces the recurrence of pain and lesions compared to cyclic use or no treatment. Continuous oral contraceptives are more effective than cyclic regimens at preventing the return of painful periods, and progestins like dienogest also reduce recurrence of endometriotic cysts.21PubMed. Prevention of the recurrence of symptom and lesions after conservative surgery for endometriosis In clinical trials, dienogest produced significant and lasting reductions in pelvic pain while progressively decreasing bleeding frequency and intensity.22PubMed Central. Reduced pelvic pain in women with endometriosis: efficacy of long-term dienogest treatment

Menstrual suppression also plays a practical role for adolescents and adults with developmental or physical disabilities, where menstrual hygiene can be a major caregiving challenge. In one population study, nearly 87% of adolescents with disabilities successfully achieved menstrual suppression through medical methods alone, with no one requiring a hysterectomy.3PubMed. Menstrual Suppression in Pediatric and Adolescent Patients with Disabilities Ranging from Developmental to Acquired Conditions Caregiver and patient satisfaction is generally high. In a separate cohort, about 85% of patients were satisfied with their final bleeding pattern, and satisfaction was strongly tied to how much bleeding reduction they achieved.23PubMed. Satisfaction With Hormonal Treatment for Menstrual Suppression in Adolescents and Young Women With Disabilities Stabilizing the hormonal environment through suppression can also improve the management of conditions like epilepsy and diabetes, where hormonal fluctuations during the menstrual cycle can worsen symptoms.24PubMed Central. Menstrual suppression: current perspectives

Dealing with Breakthrough Bleeding

Regardless of which hormonal method you choose, breakthrough bleeding is the most common frustration. It does not mean the method is failing; it usually reflects the uterine lining adjusting to a new hormonal environment. Progestin-only methods cause bleeding through changes in the endometrium driven by continuous progestin exposure, while combined methods can trigger it through hormonal fluctuations or insufficient stabilization of the lining.25PubMed Central. Understanding Problematic Bleeding When Using Contraception: Guidance for Clinicians

For most people, the spotting improves within three to six months. If it does not, switching methods or adjusting the dose often helps. The planned hormone-free interval mentioned earlier for ring users is one well-studied tool. Others include temporarily adding a short course of estrogen or switching from a progestin-only pill to a combined formulation. The key insight is that early breakthrough bleeding is not a sign that the method will never work for you. It is part of the transition period, and persistence usually pays off.

Fertility After Long-Term Suppression

If you choose a reversible method, you can almost always get your period back and become pregnant after stopping. Hormonal IUDs, implants, the depot shot, and oral contraceptives all allow fertility to return. The timeline varies: after an IUD or implant is removed, ovulation typically resumes within weeks. After continuous oral contraceptives, periods generally return within one to three months, though a systematic review noted that no formal data set has tracked return to fertility specifically after extended continuous pill use.26PubMed. Evidence about extending the duration of oral contraceptive use to suppress menstruation After the depot shot, the return can be slower, sometimes taking six months or longer, because the hormone clears from the body gradually.

The methods that are not reversible should be treated as such. Endometrial ablation makes the uterus unsuitable for carrying a pregnancy. Hysterectomy is permanent. And while testosterone therapy in transmasculine individuals generally allows a return of ovulation after discontinuation, the long-term effects on egg quality and fertility are still being studied. If there is any chance you might want biological children, preserving reversibility should be a central part of the conversation with your provider.

How Many Periods Are “Natural”

One common worry is that stopping your period is somehow going against nature, and that monthly menstruation is necessary for health. Evolutionary data complicates this narrative considerably. Studies of the Dogon of Mali, a population that does not use modern contraception, found that women who were not sterile had a median of only two menstrual periods over a two-year observation window, because they spent most of their reproductive years either pregnant or breastfeeding. The estimated lifetime total was around 100 periods, roughly a third the number experienced by a typical American woman with three children.27PubMed. Menstrual cycling and breast cancer: an evolutionary perspective

The roughly 450 periods a modern woman in a high-income country experiences is historically and evolutionarily unusual. Our reproductive systems were shaped in an environment where most of those cycles simply would not have happened. This does not prove that suppressing periods is beneficial, but it does undercut the idea that having a monthly bleed is a biological imperative. From a medical standpoint, there is no known health requirement for menstruation in someone who is not trying to conceive. The bleed during a placebo week on birth control pills is not even a real period in the physiological sense; it is a withdrawal bleed designed decades ago to make the pill feel more “natural” to regulators and users.